EU-OPENSCREEN DRIVE

STRUCTURE AND PARTNERS

 

Consortium

Our consortium joints together 34 partners from 15 different European member or associated states. Its core consists of a group of national partner sites of the EU-OPENSCREEN ERIC, which will provide access to their services and expertise in the field of small-molecule screening and medicinal chemistry.

This group is complemented by several key institutions granting expertise and excellence in scientific areas such as chemoproteomics and fragment-based screening that will be the subject for extension of the ERIC´s capacities and competences.

 

Coordinator

 

CZ

Institute of Molecular Genetics of the ASCR (IMG)

CZ

Institute of Molecular and Translational Medicine, Palacky University (IMTM)

DE

Helmholtz Centre for Infection Research (HZI)

NO

Centre for Molecular Medicine Norway, University of Oslo (UiO-NCMM)

DE

Fraunhofer IME ScreeningPort (IME)

ES

Fundación MEDINA (MEDI)

ES

Príncipe Felipe Research Center (CIPF)

ES

University of Santiago de Compostela - Biofarma (USC)

FI

University of Helsinki (UH)

High Throughput Biomedine Unit, Institute for Molecular Medicine Finland (FIMM)

NO

University of Bergen (UiB)

NO

The Arctic University of Norway (UiT)

NO

SINTEF (SIN)

PL

Institute of Medical Biology of Polish Academy of Sciences (IMB)

PL

Institute of Bioorganic Chemistry Polish Academy of Sciences (IBCH-PAS)

CZ

Masaryk University (MU)

DK

Technical University of Denmark (DTU)

ES

Spanish National Research Council (CSIC)

LV

Latvian Institute of Organic Synthesis (OSI)

PL

Institute of Biochemistry and Biophysics of Polish Academy of Sciences (IBB)

ES

Mar Institute of Medical Research Foundation (IMIM)

CZ

CSC- IT Center for Science (CSC)

DE

European Molecular Biology Laboratory (EMBL)

DE

Hochschule Mannheim (MUAS-CeMOS)

DE

Technical University Munich, Chair of Proteomics and Bioanalytics (TUM)

GR

National Centre of Scientific Research "Demokritos” (NCSRD)

SW

Karolinska Institute (KI)

PT

Institute for Molecular and Cell Biology, University of Porto (IBMC)

NL

Leiden University Medical Center (LUMC)

IL

Weizmann Institute of Science (Weizmann)

HU

Natural Science Research Center of the Hungarian Academy of Sciences (MTATTK)

RO

Institute of Chemistry of the Romanian Academy (ICT)

CH

École polytechnique fédérale de Lausanne (EPFL)

DE

Leibniz Research Institute for Molecular Pharmacology in the Forschungsverbund Berlin e.V. (FVB-FMP)